The news sweep Friday 8 November

terminates collaboration and licensing agreements with Nykode Therapeutics, which retrieves the VB10.NEO program. Read more. Nykode is hosting a webcast. Read more.

Modulight has received PPT purchase orders worth 1,5 million USD. Read more.

BiBBInstruments is carrying out a rights issue of units of approximately SEK 36,5 million, intends to raise bridge loans of a total of SEK 3,0 million and is postponing the publication of the year-end report. Read more.

Dicot Pharmas Phase IIa clinical study has started. Read more.

BioArctic announces that Eisai updates Leqembi sales forecast to JPY 42,5 billion for fiscal year 2024. Read more.

AstraZeneca Tezspire met both primary endpoints in the Phase III WAYPOINT study. Read more.

Major shareholders and management announce redemption of TO8 in Chordate Medical. Read more.

ProstaLund announces that the first ten CoreTherm Eagle machines are being manufactured. Read more.

Vivesto option agreement for Apealea is entered into with Zhida Pharmaceutical. Read more.

Bio Vitos Pharma publishes monthly information. Read more.

Immunovia presents data from a model development study at PRECEDE Pancreatic Cancer Research Consortium. Read more.

Ray Intelligence announces that the subsidiary Innowearable moves forward with another stakeholder and terminates the process of a reverse acquisition of Mobintel LLC. Read more.

Aptahems lenders offset claims against new shares. Read more.

sectra decides on the issue of C shares, repurchase of C shares and conversion to B shares. Read more.

Management and key employees exercise warrants in Ambeas incentive program. Read more.

Invent Medic brings forward the publication of the report for Q3. Read more.

Alexandra Holland new communications manager at Getinge. Read more.